MONROVIA, Calif. — The laboratory at Terray Therapeutics is a symphony of miniaturized automation. The robots spin quickly and carry small tubes of liquid to their stations. Scientists in blue coats, sterile gloves and protective glasses monitor the machines. But what really happens is at the nanoscale: Proteins in solution combine with chemical molecules held… Read More »
MONROVIA, Calif. — The laboratory at Terray Therapeutics is a symphony of miniaturized automation. The robots spin quickly and carry small tubes of liquid to their stations. Scientists in blue coats, sterile gloves and protective glasses monitor the machines. But what really happens is at the nanoscale: Proteins in solution combine with chemical molecules held… Read More »
Prescription drugs and vaccines have revolutionized healthcare, significantly reducing deaths from disease and improving quality of life worldwide. So how do researchers, universities, hospitals, and the pharmaceutical industry decide which diseases to try to develop drugs for? Working as director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School… Read More »
Emerging social problems or opportunities can significantly impact the funding available for the development of drugs for specific diseases. When COVID-19 ravaged the world, funding from Operation Warp Speed led to vaccine development in record time. Public awareness campaigns, such as the ALS ice bucket challenge, can also directly raise money for research. This viral… Read More »